Skip to main content

Deal Alert: Rajasthan Venture invests Rs. 20 crores in International Oncology

By
From the Press Release:

Jaipur-based Rajasthan Venture Capital Fund (RVCF) has invested Rs 20 crores in International Oncology Services Private Limited (IOSPL), a super specialty cancer care company for an undisclosed equity stake. 

International Oncology has established comprehensive cancer care centres (known as International Oncology Centre) equipped with cutting edge technology at Fortis Hospital, Noida and Dr. L H Hiranandani Hospital, Mumbai. The company with an objective to make quality cancer care more accessible to the people has identified several cities in India for setting up world class cancer care centers and opening soon its next centers in Jodhpur, Rajasthan and Jalandhar, Punjab.

“The Oncology sector is currently witnessing a huge gap in terms of incidence of cancer in the country and limited quality cancer care facilities to treat the same. While the incidence of cancer is increasing at an alarming rate in India; the country faces large limitations in terms of lack of technical specialization and trained personnel. India has few public sector cancer centres, some central establishment and limited private sector participation. IOSPL through its specialized cancer care centres is set to address this burgeoning demand in India” said Mr. Rajendra Bhanawat, Chairman of RVCF. 

Mr. Pradeep K Jaisingh, CEO and MD of International Oncology Services Pvt. Ltd. said, “After setting up comprehensive cancer centres in NCR and Mumbai, we are in the process of taking world class cancer care to several other states of India and Rajasthan is a special focus area for us. This investment by RVCF will help IOSPL carry out its immediate expansion plans and we are delighted to have their support." 

“IOSPL with its professional and experienced promoters & team is expected to emerge as one of the leading cancer care company in India” said Mr. Girish Gupta, CEO of RVCF who will be joining the Board of Directors of the company. 

RVCF has invested in IOSPL through its Rs 200 crores SME Tech Fund which invests pan India in IT, education, healthcare, agro products, auto components and other growth sectors. 

ABOUT IOSPL 

International Oncology is a global cancer care and research company focused on providing world class cancer treatment and care. The company is at the forefront of bringing the very best in cancer care to India through expertise, research and collaboration. International Oncology is committed to making world class cancer care accessible to the underserved areas through their network of cancer care centres. 

After establishing their flagship centres at Noida and Mumbai, the company is in the process of launching comprehensive cancer care centres in states like Rajasthan, Punjab, Maharashtra and others. In the outreach programme, the company has tied up with various hospitals in Aligarh, Moradabad, Srinagar, Imphal, Gwalior and Panipat to make world class cancer care more accessible. 

ABOUT RVCF 

Rajasthan Venture Capital Fund is mandated to operate on pan-India basis. It manages two SEBI registered domestic venture capital funds - RVCF Fund I & SME TECH FUND – RVCF Trust II and invests in IT, education, healthcare, agro products, auto components and other growth sectors. Rajasthan Venture Capital Fund is amongst the top 3 Regional venture capital funds in India.

For more details contact Mr. Girish Gupta, CEO – Rajasthan Venture
Mobile No: +91 98290 66878/ Landline: 0141-4071680

Popular posts from this blog

EY Tops League Table for Transaction Advisors to M&A deals in 24

By
Moelis & Company & PwC claim the No.2 & No.3 slots Ernst & Young  (EY) topped the Venture Intelligence League Table for Transaction Advisor to M&A Deals   during 2024, advising 34 deals worth $4.1 Billion. Moelis & Company stood second advising 2 deals worth $3.9 billion. PwC followed with 18 deals worth $3.3 billion. Citi ($2.5 billion across 1 deal) and Advay Capital ($2.3 billion across 1 deal) completed the top five. Among the largest M&A deals in 2024, Citi  advised $2.5 Billion acquisition of the Indian business of American Tower Corporation by Brookfield , Advay Capital and Moelis & Company advised the $2.3 Billion acquisition of Care Hospitals by Aster DM Healthcare . Jefferies & Co., JP Morgan and Moelis & Company advised the $1.6 Billion acquisition of Bharat Serums & Vaccines by Mankind Pharma.  Among the other notable M&A deals in Q4 2024, EY advised the $685 million acquisition of ITD Cementation ...
Read more

Morgan Stanley tops League Table for Transaction Advisors to M&A deals in 2020

By
Morgan Stanley , which advised the $10.1 Billion strategic investment by Facebook and Google into Reliance Industries' telecom arm Jio platforms (among other Private Equity investments in the company), topped the Venture Intelligence League Table for Transaction Advisor to M&A Deals for 2020. Ambit Corporate Finance - which advised 3 deals worth $4.0 Billion, including Brookfield's $3.7 Billion acquisition of Reliance Tower Infrastructure Trust -  took the second spot. JM Financial ($3.7 Billion across 5 deals), Metta Capital ($3.4 Billion across 3 deals) and ICICI Securities ($3.4 Billion across 2 deals) - all of whom (along with Citi) are advisors to the $3.4 Billion acquisition of Future Group's retail related ventures by Reliance Retail, announced in August - completed the top five. The  Venture Intelligence League Tables , the first such initiative exclusively tracking transactions involving India-based companies, are based on the value of PE and M&A tra...
Read more

Everything you wanted to know (and some things you didn't care to know) about ChrysCapital's Ashish Dhawan

By
New Delhi-based private equity fund ChrysCapital is vastly different from its former avatar, Chrysalis Capital. While Chrysalis began life (in Mumbai) as an venture capital firm focussed on start-up investments, today's ChrysCapital is best know for its late-stage investments (often in already public companies). The fascinating part of this transformation is that one of the fund's original partners - Senior Managing Director Ashish Dhawan - has been firmly in the driver's seat throughout the process. It's a story that needed to be told. As a cover story. Kudos to Business Today for telling it first. Thankfully, unlike the glowing profiles that BT is famous for - including the one featuring infamous stock brocker Harshad Mehta with his Lexus on the cover - this one has a lot of facts. Some well known. And others less so. That ChrysCapital's first fund would have been a disaster but for the pioneering investment in Raman Roy founded BPO firm Spectramind i...
Read more

Why did Sony Entertainment Television's CEO quit?

By
Businessworld has a cover story on the corporate battle that resulted in Kunal Dasgupta, the CEO of Multi Screen Media (formerly Sony Entertainment Television), quitting just a few months before his contract was due to end. Dasgupta’s abrupt exit was the culmination of six years of tension between majority shareholder Sony Pictures Television International (SPTI) that owns 61 per cent of MSM, on one hand, and Atlas Equifinn on the other, which is a consortium of Indian shareholders (Singapore-based Rakesh Aggarwal, World Media Group director Sudesh Iyer, Shemaroo Entertainment Managing Director Raman Maroo, MobiApps Holding’s Jayesh Parekh, B.R. Sule, Sushil Shergil and actor Jackie Shroff ) holding 32 per cent. Capital Japan and some financial institutions own the rest 7 per cent. And of course, the third protagonist is Dasgupta, who walked a tightrope and managed to keep his job for over 14 years despite the fact that neither group of shareholders was too happy with him. Very little...
Read more

APEX VC Awards: Chiratae Ventures, Blume Ventures, Elevation Capital, Stride Ventures & Alteria Capital judged best funds of 2021

By
Press Release Elevation Capital , Chiratae Ventures , Blume Ventures , Stride Ventures and Alteria Capital were voted the top Venture Capital investors in India during 2021. The Venture Intelligence “Awards for Private Equity Excellence” (APEX) is dedicated to celebrating the best that the Indian Private Equity & Venture Capital industry has to offer. "VCs exist because Entrepreneurs exist and disrupt the ecosystem by creating new businesses. We are very excited to be part of the secular trend of tech disruption that would power India’s journey towards $ 10 Trillion economy over the next decade," said  T C Meenakshi Sundaram, Founder & Vice Chairman, Chiratae Ventures , winner of " VC Fund raise of the Year " award.  " We wish to thank all our entrepreneurs who have chosen to take funding from Chiratae Ventures and investors who have backed us with funds over the past 15 years in this journey.  Congratulations to the entire Chiratae Ventures team and ...
Read more